Back

Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes

Gristick, H. B.; Hartweger, H.; Nishimura, Y.; Gavor, E.; Nagashima, K.; Koranda, N. S.; Gnanapragasam, P. N. P.; Kakutani, L. M.; Segovia, L.; Donau, O.; Keeffe, J. R.; West, A. P.; Martin, M. A.; Nussenzweig, M. C.; Bjorkman, P. J.

2025-01-09 bioengineering
10.1101/2025.01.08.632013 bioRxiv
Show abstract

A primary goal in the development of an AIDS vaccine is the elicitation of broadly neutralizing antibodies (bNAbs) that protect against diverse HIV-1 strains. To this aim, germline-targeting immunogens have been developed to activate bNAb precursors and initiate the induction of bNAbs. While most pre-clinical germline-targeting HIV-1 vaccine candidates only include a single bNAb precursor epitope, an effective HIV-1 vaccine will likely require bNAbs that target multiple epitopes on Env. Here, we report a newly designed germline-targeting Env SOSIP trimer, named 3nv.2, that presents three bNAb epitopes on Env: the CD4bs, V3, and V2 epitopes. 3nv.2 forms a stable trimeric Env and binds to bNAb precursors from each of the desired epitopes. Immunization experiments in rhesus macaques and mice demonstrate 3nv.2 elicits the combined effects of its parent immunogens. Our results provide proof-of-concept for using a germline-targeting immunogen presenting three or more bNAb epitopes and a framework to develop improved next-generation HIV-1 vaccine candidates.

Published in Journal of Experimental Medicine (predicted rank #7) · training set

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.